Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy

Progress in Neurobiology

Volumn 54, Issue 6, 1998, Pages 721-741

  Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENOBARBITAL; VALPROIC ACID;

CIRCLING BEHAVIOR; DRUG RECEPTOR BINDING; EPILEPSY; KINDLING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; STEREOTYPY;

EID: 0141722008     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00092-0     Document Type: Article

References (110)

1. Adamec, R. E. (1990) Does kindling model anything clinically relevant? Biol. Psychiatry 27, 249-279.
2. Akiyama, K., Daigen, A., Yamada, N., Itoh, T., Kohiro, I., Ujike, H. and Otsuki, S. (1992) Long-lasting enhancement of metabotropic excitatory amino acid receptor-mediated polyphosphoinositide hydrolysis in the amygdala/piriform cortex of deep prepiriform cortical kindled rats. Brain Res. 569, 71-77.
3. Alghoul, W. M., Meeker, R. B. and Greenwood, R. S. (1995) Kindling induces a long-lasting increase in brain nitric oxide synthase activity. Neuroreport 6, 457-460.
4. Attwell, P. J., Kaura, S., Sigala, G., Bradford, H. F., Croucher, M. J., Jane, D. E. and Watkins, J. C. (1995) Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res. 698, 155-162.
5. Bacia, T., Szpiro-Zurkowska, A., Bidzinski, J. and Czarkwiani, L. (1989) Use of ketamine for activation of EEG and electrocorticographic records in patients with epilepsy. Epilepsia 30, 642.
6. Bettler, B. and Mulle, C. (1995) Neurotransmitter receptors II: AMPA and kainate receptors. Neuropharmacology 34, 123-139.
7. Bockaert, J., Pin, J. and Fagni, L. (1993) Metabotropic glutamate receptors: an original family of G protein-coupled receptors. Fundam. Clin. Pharmacol. 7, 473-485.
8. Bradford, H. F. (1995) Glutamate, GABA and epileopsy. Progr. Neurobiol. 47,.
9. Bristow, L. J., Hutson, P. H., Kulagowski, J. J., Leeson, P. D., Matheson, S., Murray, F., Rathbone, D., Saywell, K. L., Thorn, L., Watt, A. P. and Tricklebank, M. D. (1996) Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther. 279, 492-501.
10. Carter, A. J. (1992) Glycine antagonists: regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future 17, 595-613.
11. Carter, A. J. (1994) Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J. Pharmacol. Exp. Ther. 269, 573-580.
12. Carter, A. J. (1995) Antagonists of the NMDA receptor-channel complex and motor coordination. Life Sci. 57, 917-929.
13. Chapman, A. G., Durmuller, N., Harrison, B. L., Baron, B. M., Parvez, N. and Meldrum, B. S. (1995) Anticonvulsant activity of a novel NMDA glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures. Eur. J. Pharmacol. 274, 83-88.
14. Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D. and Bleakman, D. (1997) A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389, 599-603.
15. Cotman, C. W., Kahle, J. S., Miller, S. E., Ulas, J. and Bridges, R. J. (1995) Excitatory amino acid neurotransmission. In: Psychopharmacology. The fourth generation of progress, 75-85. Edited by Bloom, F. E. and Kupfer, D. J. New York, Raven Press.
16. Cotterell, K. L., Croucher, M. J. and Bradford, H. F. (1992) Weak anticonvulsant activity of CGP-37849 and CGP-39551 against kindled seizures following systemic administration. Eur. J. Pharmacol. 214, 285-287.
17. Croucher, M. J., Cotterell, K. L. and Bradford, H. F. (1992) Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochem Int. 17, 409-413.
18. Croucher, M. J. and Bradford, H. F. (1990a) Anticonvulsant and antiepileptogenic actions of a strychnine-insensitive glycine receptor antagonist in the kindling model of epilepsy. Brit. J. Pharmacol. 100(Suppl), 387P.
19. Croucher, M. J. and Bradford, H. F. (1990b) 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling. Neurosci. Lett. 118, 29-32.
20. Dichter, M. A. (1989) Cellular mechanisms of epilepsy and potential new treatment strategies. Epilepsia 30(Suppl. 1), S12.
21. Dingledine, R., McBain, C. J. and McNamara, J. O. (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338.
22. Dürmüller, N., Craggs, M. and Meldrum, B. S. (1994) The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17, 167-174.
23. Dziki, M., Hönack, D. and Löscher, W. (1992) Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate. Eur. J. Pharmacol. 222, 273-278.
24. B receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Eur. J. Pharmacol. 322, 179-184.
25. Feeser, H. R., Kadis, J. L. and Prince, D. A. (1988) Dextromethorphan, a common antitussive, reduces kindled amygdala seizures in the rat. Neurosci. Lett. 86, 340-345.
26. Foutz, A. S., Pierrefiche, O. and Denavitsaubie, M. (1994) Combined blockade of NMDA and non-NMDA receptors produces respiratory arrest in the adult cat. Neuroreport 5, 481-484.
27. Garcia, Y., Ibarra, C. and Jaffe, E. H. (1995) NMDA and non-NMDA receptor-mediated release of [H-3]GABA from granule cell dendrites of rat olfactory bulb. J. Neurochem 64, 662-669.
28. Garthwaite, J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
29. Gilbert, M. E. (1988) The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures. Brain Res. 463, 90-99.
30. Gilbert, M. E. (1994) The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling. Epilepsy Res. 17, 145-156.
31. Goddard, G. V., McIntyre, D. C. and Leech, C. K. (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25, 295-330.
32. Herrling, P. L., Emre, M. and Watkins, J. C. (1997) D-CPPene (SDZ EAA-494) - a competitive NMDA antagonist: pharmacology and results in humans. Excitatory. Amino. Acids. -. Clinical. Results. with. Antagonists. -21.
33. Holmes, K. H., Bilkey, D. K., Laverty, R. and Goddard, G. V. (1990) The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Brain Res. 506, 227-235.
34. Holmes, K. H., Keele, N. B. and Shinnickgallagher, P. (1996) Loss of mGluR-mediated hyperpolarizations and increase in mGluR depolarizations in basolateral amygdala neurons in kindling-induced epilepsy. J. Neurophysiol. 76, 2808-2812.
35. Hönack, D. and Löscher, W. (1993) Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620, 167-170.
36. Imperato, A., Scrocco, M. G., Bacchi, S. and Angelucci, L. (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187, 555-556.
37. 3H]kainate binding. Eur. J. Pharmacol. 246, 195.
38. Jorgensen, M., Tygesen, C. K. and Andersen, P. H. (1995) Ionotropic glutamate receptors - focus on non-NMDA receptors. Pharmacol. Toxicol. 76, 312-319.
39. Kemp, J. A. and Leeson, P. D. (1994) The glycine site of the NMDA receptor - five years on. Trends Pharmacol. Sci. 14, 20-25.
40. Koek, W. and Colpaert, F. C. (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther. 252, 349-357.
41. Kraus, J. E., Yeh, G. C., Bonhaus, D. W., Nadler, J. V. and McNamara, J. O. (1994) Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J. Neurosci. 14, 4196-4205.
42. Lapin, I. P., Prakhie, I. B. and Kiseleva, I. P. (1982) Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice. J. Neural Trans. 54, 229-238.
43. Lees, G. J. (1996) Therapeutic potential of AMPA receptor ligands in neurological disorders. Cns. Drugs 5, 51-74.
44. Lerma, J., Morales, M., Vicente, M. A. and Herreras, O. (1997) Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20, 9-12.
45. Lipton, S. A. (1993) Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16, 527-532.
46. Lothman, E. W. (1996) Neurobiology as a basis for rational polypharmacy. Epilepsy Res. 11(Suppl), 3-7.
47. Löscher, W., Nolting, B. and Hönack, D. (1988) Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur. J. Pharmacol. 152, 9-17.
48. Löscher, W. (1989) GABA and the epilepsies. Experimental and clinical considerations. In: GABA. Basic research and clinical applications, 260-300. Edited by Bowery, N. G. and Nisticò, G. Rome, Pythagora Press.
49. Löscher, W., Annies, R. and Hönack, D. (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128, 191-194.
50. Löscher, W. (1993) Basic aspects of epilepsy. Curr. Opin. Neurol. Neurosurg. 6, 223-232.
51. Löscher, W., Annies, R. and Hönack, D. (1993a) Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J. Pharmacol. 242, 263-274.
52. Löscher, W., Rundfeldt, C. and Hönack, D. (1993b) Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5, 1545-1550.
53. Löscher, W., Wlaz, P., Rundfeldt, C., Baran, H. and Hönack, D. (1994) Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Brit. J. Pharmacol. 112, 97-106.
54. Löscher, W. (1998) Animal models of epilepsy and epileptic seizures. In: Antiepileptic drugs. Handbook of experimental pharmacology, in press. Edited by Eadie, M. J. and Vajda, F. Berlin, Springer.
55. Löscher, W. (1998) New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. in press.
56. Löscher, W. and Hönack, D. (1990) High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 476-481.
57. Löscher, W. and Hönack, D. (1991a) Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol. Sci. 12, 52.
58. Löscher, W. and Hönack, D. (1991b) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256, 432-440.
59. Löscher, W. and Hönack, D. (1991c) The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotoniniA receptors. J. Pharmacol. Exp. Ther. 257, 1146-1153.
60. Löscher, W. and Hönack, D. (1993a) Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats. Eur. J. Pharmacol. 238, 191-200.
61. Löscher, W. and Hönack, D. (1993b) Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats. Eur. J. Pharmacol. 234, 237-245.
62. Löscher, W. and Hönack, D. (1994) Over-additive anticonvulsant effect of memantine and NBQX in kindled rats. Eur. J. Pharmacol. 259, R3-R5.
63. Löscher, W. and Schmidt, D. (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations Epilepsy Res. 2, 145-181.
64. Löscher, W. and Schmidt, D. (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17, 95-134.
65. McDonald, J. W., Fix, A. S., Tizzano, J. P. and Schoepp, D. D. (1993) Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J. Neurosci. 13, 4445-4455.
66. McManigle, J. E., Taveira DaSilva, A. M., Dretchen, K. L. and Gillis, R. A. (1994) Potentiation of MK-801-induced breathing impairment by 2,3-dihydro-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Eur. J. Pharmacol. 252, 11-17.
67. McNamara, J. O., Russell, R. D., Rigsbee, L. and Bonhaus, D. W. (1988) Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27, 563-568.
68. McNamara, J. O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci. 14, 3413-3425.
69. Meldrum, B. S. (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res. 12, 189-196.
70. Meldrum, B. S., Craggs, M. D., Durmuller, N., Smith, S. E., Chapman, A. G., Bowery, N. G., Gale, K. and Wasterlain, C. G. (1992) The effects of AMPA-receptor antragonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res. 9(Suppl.), 307-311.
71. Miller, D. W. and Abercrombie, E. D. (1996) Effects of MK-801 on spontaneous and amphetamine- stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res. Bull. 40, 57-62.
72. Morimoto, K., Katayama, K., Inoue, K. and Sato, K. (1991) Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 40, 893-899.
73. Morimoto, K. and Namba, T. (1993) Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Soc. Neurosci. Abstr. 19, 1467.
74. Namba, T., Morimoto, K., Yamada, N. and Otsuki, S. (1993) Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats. Pharmacol. Biochem. Behav. 46, 275-281.
75. Namba, T., Morimoto, K., Sato, K., Yamada, N. and Kuroda, S. (1994) Antiepileptogenic and anticonvulsant effects of NBQX, a selective ampa receptor antagonist, in the rat kindling model of epilepsy. Brain Res. 638, 36-44.
76. Neugebauer, V., Keele, N. B. and Shinnick-Gallagher, P. (1997) Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J. Neurosci. 17, 983-995.
77. Nicoletti, F., Bruno, V., Copani, A., Casabona, G. and Knöpfel, T. (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19, 267-271.
78. Perouansky, M. and Grantyn, R. (1990) Is GABA release modulated by presynaptic excitatory amino acid receptors? Neurosci. Lett. 113, 292-297.
79. Racine, R. J. (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32, 281-294.
80. Rogawski, M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325-331.
81. Rogawski, M. A. (1995) Excitatory amino acids and seizures. In: CNS neurotransmitters and neuromodulators: glutamate, 219-237. Edited by Stone, T. W. Boca Raton, CRC Press.
82. Rundfeldt, C., Hönack, D. and Löscher, W. (1990) Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 29, 845-851.
83. Rundfeldt, C., Wlaz, P. and Löscher, W. (1994) Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res. 653, 125-131.
84. Rundfeldt, C., Koch, R., Richter, A., Mevissen, M., Gerecke, U. and Löscher, W. (1995) Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur. J. Pharmacol. 274, 73-81.
85. Saitoh, H., Osonoe, K., Osonoe, M., Mori, N. and Kumashiro, H. (1991) An important role of non-NMDA receptors in the expression of kindled amygdaloid seizure in rats. Jap. J. Psychiatr. Neurol. 45, 386-387.
86. Sato, K., Morimoto, K. and Okamoto, M. (1988) Anticonvulsant action of a non-competitive antagonist of NMDA-receptors (MK-801) in the kindling model of epilepsy. Brain Res. 463, 12-20.
87. Sato, M., Racine, R. J. and McIntyre, D. C. (1990) Kindling: basic mechanisms and clinical validity. Electroenceph. Clin. Neurophysiol. 76, 459-472.
88. Saucier, D. and Cain, D. P. (1996) Competitive NMDA receptor antagonists do not block cholinergic kindling with carbachol. Epilepsy Res. 24, 9-18.
89. Sayin, U., Rutecki, P. A. and Sutula, T. P. (1996) NMDA dependant synaptic currents do not contribute to permanent seizure susceptibility after kindling. Soc. Neurosci. Abstr. 22, 187.
90. Scheuer, M. L. and Pedley, T. A. (1990) The evaluation and treatment of seizures. New Engl. J. Med. 323, 1468-1474.
91. Seeburg, P. H. (1993) The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16, 359-365.
92. Shinozaki, H. (1995) Excitatory amino acids and neuronal death. No-To-Hattatsu 27, 104-112.
93. Stone, T. W. (1993) Subtypes of NMDA receptors. Gen. Pharmacol. 825-832.
94. Suzuki, K., Mori, N., Kittaka, H., Iwata, Y., Yamada, Y., Osonoe, K. and Niwa, S. (1996) Anticonvulsant action of meta-botropic glutamate receptor agonists in kindled amygdala of rats. Neurosci. Lett. 204, 41-44.
95. Sveinsbjornsdottir, S., Sander, J. W. A. S., Upton, D., Thompson, P. J., Patsalos, P. N., Hirt, D., Emre, M., Lowe, D. and Duncan, J. S. (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16, 165-174.
96. Takazawa, A., Anderson, P. and Abraham, W. C. (1990) Effects of dextrometorphan, a nonopiod antitussive, on development and expression of amygdaloid kindled seizures. Epilepsia 31, 496-502.
97. Tizzano, J. P., Griffey, K. I., Johnson, J. A., Fix, A. S., Helton, D. R. and Schoepp, D. D. (1993) Intracerebral 1S,3R-1-aminocyclopentane-13-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists. Neurosci. Lett. 162, 12-16.
98. Trimble, M. R. (1991) Epilepsy and behaviour. Epilepsy Res. 10, 71-79.
99. Urbanska, E., Dziki, M., Kleinrok, Z., Czuczwar, S. J. and Turski, W. A. (1991) Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur. J. Pharmacol. 200, 277-282.
100. Urbanska, E., Dziki, M., Czuczwar, S. J., Kleinrok, Z. and Turski, W. A. (1992) Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures. Neuropharmacology 31, 1021-1026.
101. Verdoorn, T. A., Johansen, T. H., Drejer, J. and Nielsen, E. O. (1994) Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 269, 43-49.
102. Vincent, S. R. and Hope, B. T. (1992) Neurons that say NO. Trends Neurosci. 15, 108-113.
103. Waldmeier, P. C., Martin, P., Stocklin, K., Portet, C. and Schmutz, M. (1996) Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmied. Arch. Pharmacol. 354, 164-172.
104. Wedzony, K., Czyrak, A., Mackowiak, M. and Fijal, K. (1996) The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn-Schmied. Arch. Pharmacol. 353, 517-527.
105. Williamson, J. M. and Lothman, E. W. (1989) The effect of MK-801 on kindled seizures: implications for use and limitations as an antiepileptic drug. Ann. Neurol. 26, 85-90.
106. Wlaz, P., Ebert, U. and Löscher, W. (1994) Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Eur. J. Neurosci. 6, 1710-1719.
107. Wlaz, P., Ebert, U. and Löscher, W. (1998) Anticonvulsant effect of the polyamine site antagonist eliprodil or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats. Neuropharmacology, in press.
108. Wlaz, P. and Löscher, W. (1997) Weak anticonvulsant effects of two novel glycines receptor antagonists in the amygdala kindling model in rats. Eur. J. Pharmacol. in press.
109. Young, N. A., Lewis, S. J., Vajda, F. J. E. and Beart, P. M. (1989) Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat. Exp. Neurol. 103, 231-237.
110. Zarnowski, T., Kleinrok, Z., Turski, W. A. and Czuczwar, S. J. (1994) The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology 33, 619-624.